| Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M | Frank Vinluan | 11/25/19 | Boston |
| $100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants | Ben Fidler | 04/18/19 | Boston |
| Blackstone, Novartis Start Up Anthos With $250M and a Heart Drug | Ben Fidler | 02/27/19 | Boston |
| Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More | Frank Vinluan | 10/05/18 | National |
| Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline | Frank Vinluan | 02/01/18 | Boston |
| Flagship Bags $618M, Its Largest Raise Ever, For a New Startup Crop | Corie Lok | 12/20/17 | Boston |
| Cleave Biosciences Receives $37,000,000 Series B Financing | VentureDeal | 08/09/16 | San Francisco |
| Cleave Bio Gets $37M From Celgene, Others For Clinical Push | David Holley | 08/08/16 | San Francisco |
| Avrobio Secures $25,000,000 Series A Round | VentureDeal | 08/03/16 | Boston |
| Annexon Biosciences Lands $44,000,000 Series B Funding Round | VentureDeal | 06/23/16 | San Francisco |
| GrayBug Vision Receives $44,500,000 Series B Funding | VentureDeal | 05/02/16 | San Francisco |
| East Coast Biotech Roundup: PfizerGan, Nimbus, Intercept, Tesaro & More | Ben Fidler | 04/08/16 | Boston |
| Lumos Pharma Raises $34M to Fund Clinical Trials for CTD Drug | Angela Shah | 04/06/16 | Texas |
| Lumos Pharma Receives $34,000,000 Series B Round | VentureDeal | 04/06/16 | Texas |
| Entasis Therapeutics Garners $50,000,000 Series B Funding | VentureDeal | 04/05/16 | Boston |
| AstraZeneca Spinout Entasis Snags $50M For Anti-Infective Treatments | David Holley | 04/04/16 | Boston |
| Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology | Ben Fidler | 10/20/15 | San Francisco |
| Nuvelution Pharma Secures New Funding | VentureDeal | 07/14/15 | San Francisco |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout | Sarah Schmid Stevenson | 06/11/15 | Detroit Ann Arbor |
| Good Times Roll on for Biotech VCs As Clarus Bags New $500M Fund | Ben Fidler | 06/09/15 | Boston |
| AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug | Ben Fidler | 03/05/15 | National |
| Déjà Vu? Elan Alumni Start Antibody Firm to Fight Neurodegeneration | Alex Lash | 12/15/14 | San Francisco |
| East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More | Ben Fidler | 05/09/14 | Boston |
| Medtronic Scoops Up NJ-based Tyrx for $160M | Ben Fidler | 01/06/14 | New York |
| East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More | Ben Fidler | 11/15/13 | Boston |
| Catabasis Scores $32M Series B Round With IPO in Sight | Ben Fidler | 11/15/13 | Boston |
| Catabasis Pharmaceuticals Receives $32,400,000 Series B Financing | VentureDeal | 11/14/13 | Boston |
| Aerie Gets Lukewarm Reception, Cuts IPO Price to $10 Per Share | Ben Fidler | 10/25/13 | New York |
| Ophthotech Prices IPO at $22 Per Share, Reels in $167M | Ben Fidler | 09/24/13 | New York |
